國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12190/12972 (94%)
Visitors : 1076482      Online Users : 612
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Books/Book Section [5/7]
    Periodical Articles [159/159]

    Collection Statistics

    Item counts issued in 3 years:4(12.50%)
    Items With Fulltext:25(78.12%)

    Download counts of the item
    Download times greater than 0:25(100.00%)
    Download times greater than 100:22(88.00%)
    Total Bitstream Download Counts:13505(14.12%)

    Last Update: 2024-12-11 22:09


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-25 of 32. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2023-11 Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome Annals of Oncology. 2023 Nov;34(Suppl. 3):S1390.
    2023-11 The registry of genetic alterations of Taiwan NSCLC by comprehensive next-generation sequencing: A real-world cohort study - TCOG T1521 study Journal of Thoracic Oncology. 2023 Nov;18(11, Suppl.):S52.
    2022-11 BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma Annals of Oncology. 2022 Nov;33(Suppl. 9):S1472-S1473.
    2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
    2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
    2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143.
    2021-05 A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
    2019-05 An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14) Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 4101.
    2017-05 Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials Trials. 2017 May;18(Suppl. 1):Meeting Abstract P36.
    2016-11-11 Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics. 2016 Nov 11:127-136.
    2016-10 The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
    2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
    2015-05 Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101.
    2015-05 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
    2014-10 Use of a bayesian approach to design and evaluation of NCE2 Pharmacoepidemiology and Drug Safety. 2014 Oct;23(S1):432.
    2014-09 The effect of intervention with potassium and magnesium-enriched salt on neurological performance in stroke patients Cerebrovascular Diseases. 2014 Sep;38(Suppl. 1):98.
    2014-04 Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis Journal of Hepatology. 2014 Apr;60(1):S206-S207.
    2013-09 Use of random effect models in the design and analysis of multi-regional clinical trials Topics in Applied Statistics. 2013 Sep;55:325-344.
    2013-05 Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032.
    2011-05 Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
    2011-05 The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
    2011-05 Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
    2010-11 Medical resources utilization of five most prevalent cancers in Taiwan (lung cancer, liver cancer, colorectal cancer, gastric cancer, and brest cancer): 2001 similar to 2007 Value in Health. 2010 Nov;13(7):A279.
    2008-11 A population study on the age-specific relationship between body mass index, metabolic disorders, and utilization of ambulatory services Value in Health. 2008 Nov;11(6):A648.
    2008-02 Increased risk for entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan PLoS Neglected Tropical Diseases. 2008 Feb;2(2):Article number e175

    Showing items 1-25 of 32. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback